HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
- Olivier Manches,
- ,
- Anahita Fallahi,
- Jeffrey Lifson,
- Laurence Chaperot,
- Joel Plumas
- New York University,
- ,
- SAIC,
- Université Grenoble Alpes,
- Etablissement français du sang
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Plasmacytoid DCs (pDCs) have been implicated as crucial cells in antiviral immune responses. On recognizing HIV, they become activated, secreting large amounts of IFN-α and inflammatory cytokines, thereby potentiating innate and adaptive antiviral immune responses. Here, we have shown that HIV-stimulated human pDCs can also induce the differentiation of naive CD4+ T cells into Tregs with suppressive function. This differentiation was independent of pDC production of IFN-α and primarily dependent on pDC expression of indoleamine 2,3-dioxygenase, which was induced through the TLR/MyD88 pathway, following binding of HIV to CD4 and triggering of TLR7 by HIV genomic RNA. Functionally, the Tregs induced by pDCs were shown to inhibit the maturation of bystander conventional DCs. This study therefore reveals what we believe to be a novel mechanism by which pDC may regulate and potentially limit anti-HIV immune responses.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 3431-3439 (9 pages)Journal (Volume, Issue Number)
Journal of Clinical Investigation (Volume 118, Issue 10)Publication milestones
- Published - 10/01/2008
Publication status
ISSN
0021-9738Publication IDs
- Scopus: 55849140547
- PubMed: 18776940
- ORCID: /0000-0002-7711-2858/work/58011317
